Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-11-20
2007-11-20
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S231500, C514S461000, C544S147000, C549S295000, C548S265800, C548S265800
Reexamination Certificate
active
10970344
ABSTRACT:
The present invention provides compounds, compositions and methods for the selective inhibition of cathepsin S. In a preferred aspect, cathepsin S is selectively inhibited in the presence of at least one other cathepsin isozyme. The present invention also provides methods for treating a disease state in a subject by selectively inhibiting cathepsin S.
REFERENCES:
patent: 6103711 (2000-08-01), Bemis et al.
patent: 6716818 (2004-04-01), Cai et al.
patent: WO 02/42278 (2002-05-01), None
Alper Phillip
Karanewsky Donald
Liu Hong
Mutnick Daniel
Anderson Rebecca
Barker Michael P.
IRM LLC
The Genomics Institute of the Novartis Research Foundation
Tongco Wu Emily
LandOfFree
Inhibitors of cathepsin S does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of cathepsin S, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of cathepsin S will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3873103